MARCHEX INC (MCHX) — SEC Filings

Latest SEC filings for MARCHEX INC (MCHX), explained in plain English.

Sentiment Overview: 1 bearish, 35 neutral, 2 mixed

Recent Filings (38)

• Marchex Inc. Files S-8 for Employee Stock Plan — S-8 · 2026-04-09T16:15:25-04:00 [neutral] Risk: medium
  Marchex Inc. filed an S-8 form on April 9, 2026, to register an unspecified number of shares of common stock to be offered under its 2024 Equity Incentive Plan.
• Marchex Leans into AI for Conversational Intelligence Growth — 10-K · 2026-03-26T08:45:19-04:00 [mixed] Risk: medium
  Marchex, Inc. (MCHX) filed its 10-K for the fiscal year ended December 31, 2025, emphasizing its strategic shift towards AI and conversation intelligence. The c
• Marchex Files 8-K on Financial Results, Operations — 8-K · 2026-03-25T16:20:07-04:00 [neutral]
  Marchex Inc. filed an 8-K on March 25, 2026, announcing its results of operations and financial condition, as detailed in Item 2.02. This filing includes an exh
• Marchex Files 8-K: Board Changes, Agreements, and Shareholder Votes — 8-K · 2025-12-17T00:00:00.000Z [neutral] Risk: medium
  On December 16, 2025, Marchex, Inc. filed an 8-K report detailing several significant events. These include the entry into a material definitive agreement, the
• Marchex Q3 Loss Widens on Revenue Dip, Cash Declines — 10-Q · 2025-11-14T00:00:00.000Z [bearish] Risk: high
  Marchex, Inc. reported a net loss of $1.02 million for the three months ended September 30, 2025, an increase from the $0.83 million net loss in the same period
• 8-K Filing — 8-K · 2025-11-13T00:00:00.000Z [neutral]
• Marchex Sets 2025 Annual Meeting; Horowitz Dominates Voting Power — DEF 14A · 2025-11-04T00:00:00.000Z [neutral] Risk: medium
  Marchex, Inc. (MCHX) is holding its 2025 Annual Meeting of Stockholders on December 16, 2025, to elect five directors and ratify RSM US LLP as its independent a
• Marchex Board Shakeup: Two Directors Depart, Two New Ones Appointed — 8-K · 2025-10-17T00:00:00.000Z [neutral] Risk: medium
  On October 16, 2025, Marchex, Inc. announced the departure of two directors, Michael E. Binger and Christopher L. Jones. The company also elected two new direct
• Marchex Inc. Files 8-K: Material Agreement & Officer Changes — 8-K · 2025-09-16T00:00:00.000Z [neutral] Risk: medium
  Marchex Inc. announced on September 11, 2025, a material definitive agreement and changes in its board and officer composition. The company also filed financial
• Marchex Narrows H1 Loss, Posts Q2 Profit Amid Revenue Dip — 10-Q · 2025-08-13T00:00:00.000Z [mixed] Risk: medium
  Marchex, Inc. reported a net income of $85 thousand for the three months ended June 30, 2025, a significant improvement from a net loss of $756 thousand in the
• Marchex Inc. Files 8-K on Financials — 8-K · 2025-08-12T00:00:00.000Z [neutral] Risk: low
  Marchex, Inc. filed an 8-K on August 12, 2025, to report on its Results of Operations and Financial Condition, as well as to file Financial Statements and Exhib
• Marchex Inc. Files Q1 2025 10-Q — 10-Q · 2025-05-14T00:00:00.000Z [neutral] Risk: medium
  Marchex Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025
• Marchex Inc. Files 8-K on Financials — 8-K · 2025-05-13T00:00:00.000Z [neutral] Risk: low
  Marchex, Inc. filed an 8-K on May 13, 2025, to report on its results of operations and financial condition, as well as to provide a Regulation FD disclosure. Th
• Marchex Files 2024 Annual Report Amendment — 10-K/A · 2025-04-18T00:00:00.000Z [neutral] Risk: low
  Marchex, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 18, 2025, provides up
• Marchex Announces Material Agreement and Officer Changes — 8-K · 2025-03-21T00:00:00.000Z [neutral] Risk: medium
  Marchex, Inc. announced on March 20, 2025, the entry into a material definitive agreement and changes in its board and officer composition. The company also rep
• Marchex Inc. Files 2024 Annual Report — 10-K · 2025-03-14T00:00:00.000Z [neutral] Risk: medium
  Marchex Inc. filed its 10-K report for the fiscal year ending December 31, 2024, on March 14, 2025. The company, headquartered in Seattle, WA, operates in the b
• Marchex, Inc. Files 8-K with Material Agreements and Officer Changes — 8-K · 2025-03-06T00:00:00.000Z [neutral] Risk: medium
  On March 6, 2025, Marchex, Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement, reported on its resu
• Marchex, Inc. Announces Executive and Director Changes — 8-K · 2025-01-10T00:00:00.000Z [neutral] Risk: medium
  On January 10, 2025, Marchex, Inc. filed an 8-K report detailing changes in its executive and director positions. The filing indicates the departure of certain
• Marchex, Inc. Reports Director Changes and New Agreements — 8-K · 2024-12-31T00:00:00.000Z [neutral] Risk: medium
  On December 31, 2024, Marchex, Inc. filed an 8-K report indicating changes in its board of directors and certain officers. The filing also disclosed the entry i
• Marchex Announces Material Agreement & Officer Changes — 8-K · 2024-11-07T00:00:00.000Z [neutral] Risk: medium
  On November 6, 2024, Marchex, Inc. announced a material definitive agreement and changes in its board and officer composition. The company also reported on comp
• Marchex Files Q3 2024 10-Q — 10-Q · 2024-11-01T00:00:00.000Z [neutral] Risk: medium
  Marchex Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter of 2024, detailing revenues,
• Marchex Inc. Files 8-K on Operations and Shareholder Votes — 8-K · 2024-10-31T00:00:00.000Z [neutral] Risk: low
  Marchex, Inc. filed an 8-K on October 31, 2024, reporting on results of operations, financial condition, and matters submitted to a vote of security holders. Th
• Marchex Files 2024 Proxy Statement — DEF 14A · 2024-09-18T00:00:00.000Z [neutral] Risk: low
  Marchex, Inc. filed its definitive proxy statement on September 18, 2024, for its annual meeting of stockholders. The filing, designated as DEF 14A, outlines th
• Marchex Files Q2 2024 10-Q — 10-Q · 2024-08-13T00:00:00.000Z [neutral] Risk: medium
  Marchex Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key fi
• Marchex Inc. Files 8-K on Financials — 8-K · 2024-08-08T00:00:00.000Z [neutral] Risk: low
  On August 8, 2024, Marchex, Inc. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, provi
• Marchex Inc. Announces Board Changes and Officer Compensation — 8-K · 2024-07-29T00:00:00.000Z [neutral] Risk: medium
  On July 26, 2024, Marchex, Inc. announced the departure of director Michael E. Murphy and the appointment of new directors, including David J. Glickman and Davi
• Marchex Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · 2024-05-14T00:00:00.000Z [neutral] Risk: low
  MARCHEX INC (MCHX) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Marchex Inc. filed its quarterly report (10-Q) on May 14, 2024, for the period
• Marchex Inc. Files 8-K/A Amendment — 8-K/A · 2024-05-08T00:00:00.000Z [neutral] Risk: medium
  Marchex, Inc. filed an amendment (8-K/A) on May 8, 2024, to its previous report dated May 7, 2024. This amendment pertains to the company's results of operation
• Marchex Inc. Enters Material Definitive Agreement — 8-K · 2024-05-07T00:00:00.000Z [neutral] Risk: medium
  On May 7, 2024, Marchex, Inc. entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement, its terms, or any
• Marchex, Inc. Files Amendment to Annual Report — 10-K/A · 2024-04-29T00:00:00.000Z [neutral] Risk: low
  MARCHEX INC (MCHX) filed a Amended Annual Report (10-K/A) with the SEC on April 29, 2024. Marchex, Inc. filed a 10-K/A (Amendment No. 1) for the fiscal year end
• Marchex Inc. Files 2023 Annual Report on Form 10-K — 10-K · 2024-04-01T00:00:00.000Z [neutral] Risk: medium
  MARCHEX INC (MCHX) filed a Annual Report (10-K) with the SEC on April 1, 2024. Marchex Inc. filed its 10-K report for the fiscal year ending December 31, 2023.
• Marchex Inc. Files 8-K on Financials — 8-K · 2024-03-14T00:00:00.000Z [neutral] Risk: low
  Marchex, Inc. filed an 8-K on March 14, 2024, reporting on its results of operations and financial condition, and filing financial statements and exhibits. The
• SC 13G/A Filing — SC 13G/A · 2024-03-01T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-02-14T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Koller Capital Discloses 3.86M Shares in Marchex, Inc. — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  Koller Capital LLC, a Delaware-based investment firm, filed an amended SC 13G/A on February 9, 2024, disclosing its beneficial ownership of 3,865,175 shares of
• Marchex, Inc. Files 10-Q/A Amendment — 10-Q/A · 2024-02-08T00:00:00.000Z [neutral] Risk: low
  MARCHEX INC (MCHX) filed a Amended Quarterly Report (10-Q/A) with the SEC on February 8, 2024. Marchex, Inc. filed a 10-Q/A (Amendment No. 2) on February 8, 202
• Marchex, Inc. Files Amendment No. 1 to 10-Q for Q1 2023 — 10-Q/A · 2024-01-16T00:00:00.000Z [neutral] Risk: low
  MARCHEX INC (MCHX) filed a Amended Quarterly Report (10-Q/A) with the SEC on January 16, 2024. Marchex, Inc. filed an amendment (10-Q/A) to its quarterly report